----
Forecast & Rating2 analysts currently cover Lisata Therapeutics, of which 0 give a positive rating. The average price target is $4.00, about 292.2% upside from the current price of $1.02. Coverage is limited, so the data is for reference only. Data as of Jul 27, 2026; this does not constitute investment advice.
Jul 27, 2026Price forecast
$4.00292.16%
Forecast & RatingHold
2analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
- Strong buy
- 0
- Buy
- 0
- Hold
- 2
- Sell
- 0
- Strong sell
- 0
Target price forecast
Forecast dateOct 26, 2026
Forecast met0.0%
Stock price$1.02
Avg. target$13.0
High target$15
Low target$9
- Avg. target
- $13.0
- High target
- $15
- Low target
- $9
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.
